SEPN
Septerna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.38
+0.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.39x
- Price / sales
- 17.17x
- Price / cash flow
- 16.02x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 13.64x
- EV / EBITDA
- -34.29x
- EV / EBIT
- -30.96x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026